|
PDCD11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.861900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.362960E-01 |
| Normal-vs-Stage2 |
8.898100E-02 |
| Normal-vs-Stage3 |
2.391500E-02 |
| Normal-vs-Stage4 |
7.297600E-02 |
| Stage1-vs-Stage2 |
5.538000E-01 |
| Stage1-vs-Stage3 |
2.857600E-01 |
| Stage1-vs-Stage4 |
5.675600E-01 |
| Stage2-vs-Stage3 |
8.641800E-01 |
| Stage2-vs-Stage4 |
9.717200E-01 |
| Stage3-vs-Stage4 |
8.222800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.158150E-01 |
| Normal-vs-AfricanAmerican |
7.731400E-01 |
| Normal-vs-Asian |
1.353360E-01 |
| Caucasian-vs-AfricanAmerican |
4.110200E-01 |
| Caucasian-vs-Asian |
8.797000E-01 |
| AfricanAmerican-vs-Asian |
3.528000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.964100E-03 |
| Normal-vs-Female |
1.414010E-01 |
| Male-vs-Female |
5.671700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.397200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.447500E-02 |
| Normal-vs-Age(61-80Yrs) |
8.148400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.382800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.573790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.773400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.651600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.184800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.773600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.741000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.779580E-01 |
| Classical-VS-Follicular |
1.78299999986642E-07 |
| Classical-VS-Other |
4.104100E-02 |
| Classical-VS-Normal |
5.316600E-01 |
| Tall-VS-Follicular |
8.248300E-02 |
| Tall-VS-Other |
2.225000E-01 |
| Tall-VS-Normal |
1.071010E-01 |
| Follicular-VS-Other |
7.793800E-01 |
| Follicular-VS-Normal |
7.82719999999903E-05 |
| Other-VS-Normal |
2.431800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.434300E-02 |
| Normal-vs-N1 |
5.437900E-03 |
| N0-vs-N1 |
2.290200E-01 |
|
|
